|Articles|January 1, 2020
- BioPharm International-01-01-2020
- Volume 33
- Issue 1
BioPharm International, January 2020 Issue (PDF)
Click the title above to open the BioPharm International January 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 6 years ago
Faster, Better Bioprocessing in 2020about 6 years ago
Can Policy Keep Pace with Science and Discoveries?about 6 years ago
Mapping a Route for Cell and Gene Therapy Process Developmentabout 6 years ago
Choices for Climbing the Biopharma Career Ladderabout 6 years ago
Pharma Regulation to be Shaped by Pricing and Production Issuesabout 6 years ago
Lyophilization Presents Complex Challengesabout 6 years ago
Single-Use Bioreactors: To Scale Up or Scale Out?about 6 years ago
Therapeutic Potential of Green, Synthesized Gold Nanoparticlesabout 6 years ago
Getting to the Root of Quality ProblemsNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How Biopharma Navigates the 2026 Economic Shift
2
EC’s High-Dose Aflibercept Approval Highlights Durable Anti-VEGF Retinal Therapy
3
Beyond Transactional: Collaborative Partnerships for Rapid, Flexible Biologics Development
4
Agenus Closes $141 Million Immunotherapy Collaboration with Zydus Lifesciences
5
